Scholars@Duke

R&D costs and returns by therapeutic category

Publication ,  Journal Article
DiMasi, JA; Grabowski, HG; Vernon, J
Published in: DRUG INFORMATION JOURNAL
2004
Published version (DOI) Open Access Copy (Duke)

Duke Scholars

Henry G. Grabowski
Author Henry G. Grabowski Economics
Altmetric Attention Stats
Dimensions Citation Stats

Published In

DRUG INFORMATION JOURNAL

DOI

10.1177/009286150403800301

ISSN

0092-8615

Publication Date

2004

Volume

38

Issue

3

Start / End Page

211 / 223

Related Subject Headings

  • Statistics & Probability
  • 4905 Statistics
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 0104 Statistics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
DiMasi, J. A., Grabowski, H. G., & Vernon, J. (2004). R&D costs and returns by therapeutic category. DRUG INFORMATION JOURNAL, 38(3), 211–223. https://doi.org/10.1177/009286150403800301
DiMasi, J. A., H. G. Grabowski, and J. Vernon. “R&D costs and returns by therapeutic category.” DRUG INFORMATION JOURNAL 38, no. 3 (2004): 211–23. https://doi.org/10.1177/009286150403800301.
DiMasi JA, Grabowski HG, Vernon J. R&D costs and returns by therapeutic category. DRUG INFORMATION JOURNAL. 2004;38(3):211–23.
DiMasi, J. A., et al. “R&D costs and returns by therapeutic category.” DRUG INFORMATION JOURNAL, vol. 38, no. 3, 2004, pp. 211–23. Wos-lite, doi:10.1177/009286150403800301.
DiMasi JA, Grabowski HG, Vernon J. R&D costs and returns by therapeutic category. DRUG INFORMATION JOURNAL. 2004;38(3):211–223.

Published In

DRUG INFORMATION JOURNAL

DOI

10.1177/009286150403800301

ISSN

0092-8615

Publication Date

2004

Volume

38

Issue

3

Start / End Page

211 / 223

Related Subject Headings

  • Statistics & Probability
  • 4905 Statistics
  • 3214 Pharmacology and pharmaceutical sciences
  • 1117 Public Health and Health Services
  • 0104 Statistics